Argenx Se logo

Argenx Se share price today

(NASDAQ: ARGX)

Argenx Se share price is $652.19 & ₹56,407.91 as on 24 Jan 2025, 2.30 'hrs' IST

$652.19

12.35

(1.93%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Argenx Se share price in Dollar and Rupees. Guide to invest in Argenx Se stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Argenx Se, along with analyst recommendations, forecasts, and comprehensive financials.

Argenx Se share price movements

  • Today's Low: $637.91
    Today's High: $655.52

    Day's Volatility :2.69%

  • 52 Weeks Low: $349.86
    52 Weeks High: $678.21

    52 Weeks Volatility :48.41%

Argenx Se Returns

PeriodArgenx SeSector (Health Care)Index (Russel 2000)
3 Months
14.91%
-4.8%
0.0%
6 Months
29.4%
-5.1%
0.0%
1 Year
67.26%
2.5%
0.0%
3 Years
145.85%
10.2%
-13.0%

Argenx Se Key Statistics

in dollars & INR

Previous Close
$639.84
Open
$640.42
Today's High
$655.52
Today's Low
$637.91
Market Capitalization
$39.3B
Today's Volume
$276.1K
52 Week High
$678.21
52 Week Low
$349.86
Revenue TTM
$1.9B
EBITDA
$-150.1M
Earnings Per Share (EPS)
$-0.78
Profit Margin
-2.11%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-5.74%

How to invest in Argenx Se Stock (ARGX) from India?

It is very easy for Indian residents to invest directly in Argenx Se from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Argenx Se stock in both Indian Rupees (INR) and US Dollars (USD). Search for Argenx Se or ARGX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Argenx Se or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Argenx Se shares which would translate to 0.001 fractional shares of Argenx Se as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Argenx Se, in just a few clicks!

Returns in Argenx Se for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Argenx Se investment value today

Current value as on today

₹1,74,599

Returns

₹74,599

(+74.6%)

Returns from Argenx Se Stock

₹70,489 (+70.49%)

Dollar Returns

₹4,109 (+4.11%)

Indian investors sentiment towards Argenx Se

-29%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Argenx Se on INDmoney from India has reduced in the last 30 days as on Jan 24, 2025. -29% less investors are searching Argenx Se in the last 30 days versus the previous period.

Global Institutional Holdings in Argenx Se

  • T. Rowe Price Associates, Inc.

    9.73%

  • FMR Inc

    8.02%

  • Artisan Partners Limited Partnership

    5.88%

  • HHG PLC

    4.15%

  • Capital World Investors

    2.84%

  • venBio Select Advisor LLC

    2.07%

Analyst Recommendation on Argenx Se

Buy

    72%Buy

    24%Hold

    4%Sell

Based on 25 Wall street analysts offering stock ratings for Argenx Se(by analysts ranked 0 to 5 stars)

Based on 25 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
18
19
Hold
6
6
6
Sell
1
0
0

Analyst Forecast on Argenx Se

What analysts predicted

Upside of 9.01%

Target:

$710.97

Current:

$652.19

Insights on Argenx Se

  • Price Movement

    In the last 1 year, ARGX stock has moved up by 74.0%
  • Decreasing Revenue

    Argenx SE has experienced a decline in revenue for the last two quarters. Specifically, revenue has decreased from $877.26 million to $573.23 million, resulting in an average decrease of 34.7% per quarter.
  • Increasing Net Profit

    Argenx SE has shown consistent improvement in its net profit over the last 6 quarters, rising from a loss of $94.36 million to a profit of $91.41 million. This represents an average quarterly increase of 54.6% in profit.

Argenx Se Technicals Summary

Sell

Neutral

Buy

Argenx Se is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Argenx Se Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Argenx Se logo
1.23%
29.4%
67.26%
145.85%
346.44%
Biontech Se logo
1.23%
34.01%
18.85%
-26.4%
246.9%
Regeneron Pharmaceuticals, Inc. logo
-5.11%
-36.95%
-28.33%
12.74%
100.35%
Vertex Pharmaceuticals Incorporated logo
4.23%
-13.58%
-0.46%
88.45%
88.24%
Alnylam Pharmaceuticals, Inc. logo
9.91%
13.5%
44.91%
103.56%
127.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Argenx Se logo
NA
NA
0.0
2.11
-0.06
-0.06
NA
71.28
Biontech Se logo
160.8
NA
0.04
-3.33
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
17.02
17.02
1.05
44.99
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.1
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Argenx Se logo
Buy
$39.3B
346.44%
NA
-2.11%
Biontech Se logo
Buy
$28.1B
246.9%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$75.6B
100.35%
17.02
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$110.2B
88.24%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$34.2B
127.75%
NA
-15.86%

Argenx Se Dividend announcements

  • Argenx Se Earnings

    Argenx Se’s price-to-earnings ratio stands at None

    Read More

About Argenx Se

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease, bullous pemphigoid, myositis, primary sjögren's syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC; Empasiprubart for multifocal motor neuropath, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis. The company is developing ARGX-213 targets FcRn; ARGX-121 and ARGX-220 targets immune system; ARGX-109 targets IL-6; ARGX-118 for inflammation; and ARGX-109, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It owns VYVGART; VYVGART HYTRULO; VYVDURA; ARGENX; ABDEG; NHANCE; SIMPLE ANTIBODY; and ARGENXMEDHUB. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., and Shire International GmbH. It has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.
Organization
Argenx Se
Employees
1148
CEO
Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Industry
Health Technology

Management People of Argenx Se

NameTitle
Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
CEO & Executive Director
Mr. Karl Gubitz
Chief Financial Officer
Ms. Karen Massey
Chief Operating Officer
Mr. Filip Borgions
VP & Global Head of Technical Operations
Mr. Peter Ulrichts
Chief Scientific Officer
Ms. Beth DelGiacco
VP and Global Head of Corporate Communications & Investor Relations
Ms. Malini Moorthy
General Counsel
Mr. Arjen Lemmen M.Sc.
Vice President of Corporate Development & Strategy
Mr. Marc Schorpion
Global Head of Human Resources
Ms. Andria Wilk
Global Head of Quality

Important FAQs about investing in Argenx Se (ARGX) from India :

What is Argenx Se share price today?

Argenx Se share price today stands at $652.19, Open: $640.42 ; Previous Close: $639.84 ; High: $655.52 ; Low: $637.91 ; 52 Week High: $678.21 ; 52 Week Low: $349.86. The stock opens at $640.42, after a previous close of $639.84. The stock reached a daily high of $655.52 and a low of $637.91, with a 52-week high of $678.21 and a 52-week low of $349.86.

Can Indians buy Argenx Se shares?

Yes, Indians can invest in the Argenx Se (ARGX) from India.

With INDmoney, you can buy Argenx Se at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Argenx Se at zero transaction cost.

How can I buy Argenx Se shares from India?

It is very easy to buy Argenx Se from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Argenx Se be purchased?

Yes, you can buy fractional shares of Argenx Se with INDmoney app.

What are the documents required to start investing in Argenx Se stocks?

To start investing in Argenx Se, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Argenx Se

Today’s highest price of Argenx Se (ARGX) is $655.52.

Today’s lowest price of Argenx Se (ARGX) is $637.91.

What is today's market capitalisation of Argenx Se

Today's market capitalisation of Argenx Se ARGX is 39.3B

What is the 52 Week High and Low Range of Argenx Se

  • 52 Week High

    $678.21

  • 52 Week Low

    $349.86

What are the historical returns of Argenx Se?

  • 1 Month Returns

    1.23%

  • 3 Months Returns

    29.4%

  • 1 Year Returns

    67.26%

  • 5 Years Returns

    346.44%

Who is the Chief Executive Officer (CEO) of Argenx Se

Mr. Timothy Van Hauwermeiren EMBA, M.Sc. is the current Chief Executive Officer (CEO) of Argenx Se.